GENERIC NAME: UROKINASE - INJECTION (you-row-KYE-naze)
BRAND NAME(S): Abbokinase
WARNING: Internal bleeding may be more difficult to control with this medication than with other anticoagulant therapy. This medication must be used in a hospital setting. It should be started as soon as possible after lung blood clots have been noticed (pulmonary embolism), preferably within 7 days. Urokinase should be given within 6 hours of the first symptoms of a heart attack associated with evolving myocardial infarction.
Back to Medications Index
Get the latest health and medical information delivered direct to your inbox FREE!